251 related articles for article (PubMed ID: 1702806)
21. The immunopathology of experimental allergic encephalomyelitis (EAE). III. Differential in situ expression of strain 13 Ia on endothelial and inflammatory cells of (strain 2 x strain 13)F1 guinea pigs with EAE.
Sobel RA; Colvin RB
J Immunol; 1985 Apr; 134(4):2333-7. PubMed ID: 2579141
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
[TBL] [Abstract][Full Text] [Related]
23. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
[TBL] [Abstract][Full Text] [Related]
24. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
25. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis.
Kuchroo VK; Martin CA; Greer JM; Ju ST; Sobel RA; Dorf ME
J Immunol; 1993 Oct; 151(8):4371-82. PubMed ID: 7691946
[TBL] [Abstract][Full Text] [Related]
26. Influence of the H-2u haplotype on immune function in F1 hybrid mice. I. Antigen presentation.
Fritz RB; Skeen MJ; Ziegler HK
J Immunol; 1985 Jun; 134(6):3574-9. PubMed ID: 2580890
[TBL] [Abstract][Full Text] [Related]
27. Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope.
Fallis RJ; McFarlin DE
J Immunol; 1989 Oct; 143(7):2160-5. PubMed ID: 2476499
[TBL] [Abstract][Full Text] [Related]
28. Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein.
Trotter J; Sriram S; Rassenti L; Chou CH; Fritz RB; Steinman L
J Immunol; 1985 Apr; 134(4):2322-7. PubMed ID: 2579139
[TBL] [Abstract][Full Text] [Related]
29. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
30. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice.
Tuohy VK; Sobel RA; Lu Z; Laursen RA; Lees MB
J Neuroimmunol; 1992 Jul; 39(1-2):67-74. PubMed ID: 1377711
[TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein.
Fritz RB; Skeen MJ; Chou CH; Garcia M; Egorov IK
J Immunol; 1985 Apr; 134(4):2328-32. PubMed ID: 2579140
[TBL] [Abstract][Full Text] [Related]
32. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
Cross AH; Tuohy VK; Raine CS
Cell Immunol; 1993 Feb; 146(2):261-9. PubMed ID: 7513616
[TBL] [Abstract][Full Text] [Related]
33. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
Kumar V; Tabibiazar R; Geysen HM; Sercarz E
J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
[TBL] [Abstract][Full Text] [Related]
34. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis.
Muhallab S; Dahlman I; Wallström E
J Neuroimmunol; 2005 Apr; 161(1-2):155-61. PubMed ID: 15748954
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
[TBL] [Abstract][Full Text] [Related]
36. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.
Amor S; Groome N; Linington C; Morris MM; Dornmair K; Gardinier MV; Matthieu JM; Baker D
J Immunol; 1994 Nov; 153(10):4349-56. PubMed ID: 7525700
[TBL] [Abstract][Full Text] [Related]
37. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
38. Humoral immune recognition of proteolipid protein (PLP)-specific encephalitogenic epitopes in the SJL/J mouse.
Potter NT; Stephens TS
J Neurosci Res; 1994 Jan; 37(1):15-22. PubMed ID: 7511703
[TBL] [Abstract][Full Text] [Related]
39. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
[TBL] [Abstract][Full Text] [Related]
40. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
Samson MF; Smilek DE
J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
